Quarterly report pursuant to Section 13 or 15(d)

Supplemental Disclosure for Statements of Cash Flows (Details)

v2.4.0.8
Supplemental Disclosure for Statements of Cash Flows (Details) (USD $)
 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Class of Stock [Line Items]    
Cash paid during the period for interest $ 607,000 $ 302,000
Issued stock to 401(k) plan, shares 22,126 17,390
Preferred Stock [Member]
    
Class of Stock [Line Items]    
Series B preferred stock issued, shares 2,364.9  
Platinum Montaur Life Sciences, LLC Credit Facility [Member]
    
Class of Stock [Line Items]    
Debt instrument, principal amount 4,781,333  
General Electric Capital Corporation [Member]
    
Class of Stock [Line Items]    
Debt instrument, principal amount 25,000,000  
Fair value of warrants issued 631,000  
Deferred debt discount fees $ 1,000,000